Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction
Year: 2017
Type: article
Source: Cell Research
DOI: 10.1038/cr.2017.88
Authors: Zhong Li, Matthew Brecher, Yong-Qiang Deng, Jing Zhang, Srilatha Sakamuru, Binbin Liu, Ruili Huang, Cheri A Koetzner, Christina A Allen, Susan A Jones, Haiying Chen, Na-Na Zhang, Min Tian, Fengshan Gao, Qishan Lin, Nilesh Banavali, Jia Zhou, Nathan Boles, Menghang Xia, Laura D Kramer, Cheng-Feng Qin, Hongmin Li
Institutions: New York State Department of Health, Wadsworth Center, Beijing Institute of Microbiology and Epidemiology, National Institutes of Health, National Center for Advancing Translational Sciences, Guangdong Ocean University, Neural Stem Cell Institute, The University of Texas Medical Branch at Galveston, Dalian University, University at Albany, State University of New York, Guangzhou Eighth People's Hospital, Guangzhou Medical University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: University of Wisconsin-Madison, National Natural Science Foundation of China, China Scholarship Council, Guangdong Ocean University, National Science and Technology Major Project, National Institutes of Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences
Awards: G3418493593, Emerging Infectious Diseases Training Program, G4972101261, In vivo efficacy studies of existing drugs re-purposed for flaviviruses in mouse models, G6203999290, High throughput screening of orthosteric inhibitors of flavivirus protease, New Use of Old Drugs for Zika Virus, 5-HT2 Receptor Allosterism in Cocaine Use Disorder
OpenAlex ID: W2730438503
